M. Klisovic

发表

Interplay of RUNX 1 / MTG 8 and DNA Methyltransferase 1 in Acute Myeloid Leukemia

J. Byrd, C. Plass, G. Marcucci, 2005 .

Acute Myeloid Leukemia Interplay of RUNX 1 / MTG 8 and DNA Methyltransferase 1 in Updated

J. Byrd, C. Plass, G. Marcucci, 2005 .

Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia.

J. Byrd, C. Plass, G. Marcucci, 2005, Cancer research.

A Phase I Biological Study of MG98, an Oligodeoxynucleotide Antisense to DNA Methyltransferase 1, in Patients with High-Risk Myelodysplasia and Acute Myeloid Leukemia

J. Byrd, W. Stock, G. Marcucci, 2008, Clinical Cancer Research.

Biological Study of MG 98 , an Oligodeoxynucleotide Antisense to DNAMethyltransferase 1 , in Patients with High-RiskMyelodysplasia andAcuteMyeloid Leukemia

J. Byrd, W. Stock, Shujun Liu, 2008 .

Cellular Uptake and Intracellular Levels of the Bcl-2 Antisense G 3139 in Cultured Cells and Treated Patientswith AcuteMyeloid Leukemia

M. Caligiuri, M. Grever, J. Byrd, 2005 .

Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines.

M. Parthun, G. Marcucci, S. Katz, 2003, Investigative ophthalmology & visual science.

Depsipeptide ( FR 901228 ) Inhibits Proliferation and Induces Apoptosis in Primary and Metastatic Human Uveal Melanoma Cell Lines

M. Parthun, G. Marcucci, S. Katz, 2003 .

Depsipeptide inhibits migration of primary and metastatic uveal melanoma cell lines in vitro: a potential strategy for uveal melanoma

G. Marcucci, Shujun Liu, S. Katz, 2005, Melanoma research.

Somatostatin Analogs in Ophthalmic and Orbital Disease: A Rationale for their Use

S. Katz, D. Klisovic, M. Klisovic, 2005 .

The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy.

M. Caligiuri, C. Bloomfield, C. Plass, 2005, Blood.

Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activity.

C. Bloomfield, M. Grever, J. Byrd, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Depsipeptide (FR 901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1/ETO-positive leukemic cells

M. Grever, J. Byrd, C. Plass, 2003, Leukemia.

Chipping away at the chip bias: RNA degradation in microarray analysis

Karl Kornacker, David Newsom, Herbert Auer, 2003, Nature Genetics.

Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia.

M. Caligiuri, C. Bloomfield, M. Grever, 2003, Blood.

Differential expression of histone post-translational modifications in acute myeloid and chronic lymphocytic leukemia determined by high-pressure liquid chromatography and mass spectrometry

Michael A. Freitas, Guido Marcucci, Michael A Freitas, 2003, Journal of the American Society for Mass Spectrometry.

Cellular Uptake and Intracellular Levels of the Bcl-2 Antisense G3139 in Cultured Cells and Treated Patients with Acute Myeloid Leukemia

M. Caligiuri, M. Grever, J. Byrd, 2005, Clinical Cancer Research.

Promotes Gene Expression by Disrupting the DNA Binding of the AML1/ETO and HDAC1 Repressor Complex.

G. Marcucci, T. Shen, D. Perrotti, 2004 .

G3139, a BCL-2 antisense oligo-nucleotide, in AML.

M. Caligiuri, M. Grever, J. Byrd, 2004, Annals of hematology.